Shuvo Roy shares promise of bioartifical kidney
Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartifical kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years. The bioartificial kidney both filters toxins from the blood and performs many of the metabolic functions of the healthy kidney. And, the bioartificial kidney requires no batteries or external pumps. Roy is a faculty member in the UCSF Department of Bioengineering and Therapeutic Sciences. He discusses The Kidney Project, and the project’s latest research results, on November 16, 2010 in a San Francisco Chronicle newspaper interview with Erin Allday, and on November 17, 2010 on KQED radio’s Forum with Michael Krasney.
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.